Home
Scholarly Works
Temsirolimus (TEM) in endometrial cancer:...
Conference

Temsirolimus (TEM) in endometrial cancer: Predictors of response and progression.

Authors

Goodwin RA; Jamal R; Tu D; Walsh W; Dancey J; Oza AM; Elit L; Eisenhauer EA

Volume

28

Pagination

pp. 3090-3090

Publisher

American Society of Clinical Oncology (ASCO)

Publication Date

May 20, 2010

DOI

10.1200/jco.2010.28.15_suppl.3090

Conference proceedings

Journal of Clinical Oncology

Issue

15_suppl

ISSN

0732-183X
View published work (Non-McMaster Users)

Contact the Experts team